[[{“value”:”
California Gov. Gavin Newsom on Friday signed a bill to accelerate the study of certain psychedelics as a treatment for PTSD and other mental health conditions, the Los Angeles Times reports.
The new law, backed by veterans and sponsored by the nonprofit organization Veterans Exploring Treatment Solutions (VETS), allows the Research Advisory Panel of California to approve studies involving Schedule I and Schedule II substances without requiring the full advisory board to meet, which has been an obstacle for past research opportunities.
AB 1103, authored by Democratic Assemblymember Christopher Ward, will take effect starting January 1 after receiving the governor’s signature.
VETS co-founder and CEO Amber Capone called the signing “a pivotal moment for science, for mental health, and for every veteran who has waited too long for better treatment options.”
“AB 1103 will accelerate the research needed to transform care, not just for veterans but for all Californians affected by trauma, addiction, and depression. We extend our deep gratitude to the California legislature’s bipartisan support of this bill and to Governor Newsom for his leadership.” — Capone, in a press release
“After 13 years as a Navy SEAL and multiple deployments, I tried every conventional therapy available — none worked for me,” Marcus Capone, VETS co-founder, said in a statement. “Ibogaine gave me my life back. With AB 1103, California is leading—empowering researchers to advance rigorous studies with the urgency this work warrants. This is a thoughtful, life-affirming step, and we applaud the state for moving it forward.”
Ibogaine is currently illegal throughout the U.S. but recent research has indicated that it — and other naturally occurring psychedelics, like psilocybin and DMT — could offer significant mental health benefits.
“}]] Read More Ganjapreneur
